Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)

Update Il y a 2 ans
Reference: NCT01399606

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -


This is a multicentric International Phase III,Long term open label study(12 months)assessing the long-term safety and efficacy of BF2.649 (Pitolisant)in the treatment of Excessive Daytime Sleepiness (EDS) in narcoleptic patients with or without cataplexy.

Inclusion criteria

  • Narcolepsy ,Cataplexy